Skip to main content

Clinical benefit of readministration of gefitinib for initial gefitinib-responders with non-small cell lung cancer

Access & Citations

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.